Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...
4don MSN
Commercially viable biomanufacturing: Designer yeast turns sugar into lucrative chemical 3-HP
Using a tiny, acid-tolerant yeast, scientists have demonstrated a cost-effective way to make disposable diapers, ...
Paris summit warns about “mirror life.” Scientists call for early limits on mirror bacteria that could evade defenses and ...
The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...
Bouygues has launched a new Construction Division as of 1 January 2026, объединing Colas, Bouygues Construction and Bouygues Immobilier under the leadership of Pascal Minault to strengthen ...
About Kinaset Therapeutics, Inc. Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. With founding investors 5AM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback